搜尋結果
Will Pfizer Stock Post A Downbeat Q2?
Forbes· 1 日前Pfizer (NYSE: PFE) is scheduled to report its Q2 2024 results on Tuesday, July 30. The company ...
RBBN’s 16% Tumble Creates Buying Opportunity Amid Near-Term Challenges
Forbes· 1 日前Operating challenges from the Ukraine war have forced networking and communications technology provider Ribbon Communications ...
Fortinet: Potentially Undervalued With High Growth In Cybersecurity
Forbes· 1 日前Fortinet is undervalued due to lower projected earnings growth, presenting a buying opportunity ...
Is Eli Lilly Stock Headed Toward $1300 Levels?
Forbes· 1 日前Eli Lilly stock (NYSE: LLY) has seen its stock rise by around 50% this year, outperforming the ...
Diamond Sports Group Bankruptcy Throws Wrench Into MLB RSN Viewership Trends
Forbes· 1 日前For the past two seasons, determining the overall viewership trends on the regional sports ...
Leak Reveals A ‘Big’ Fed Earthquake Could Suddenly Smash The Price Of Bitcoin, Ethereum, XRP ...
Forbes· 1 日前surged back this week as excitement builds ahead of former president Donald Trump's ...
Does Comcast’s Theme Park Sales Drop Spell Trouble For Disney’s Q3?
Forbes· 1 日前Disney is expected to publish its Q3 FY’24 results in early August. However, Disney’s ...
Alphabet Stock Fell 5% In A Day, Why?
Forbes· 1 日前Alphabet (Google)’s stock (NASDAQ: GOOG) dropped 5% on 24th July, as compared to a 2% decrease ...
Down 14% YTD, What Lies Ahead For McDonald’s Stock Following Q2 Earnings?
Forbes· 1 日前McDonald’s stock (NYSE: MCD), a restaurant chain consisting of more than 40,000 mostly ...
Is An Earnings Beat In The Cards For Merck Stock?
Forbes· 1 日前Merck (NYSE: MRK) will report its Q2 2024 results on Tuesday, July 30. As usual, Keytruda will ...